Missouri State Highway Patrol To Evaluate CDEX Inc. (CEXI.OB) Illicit Drug Detector; CDEX To Supply Three Units As Part Of Pilot Test And Field Evaluation Program
ROCKVILLE, Md.--(BUSINESS WIRE)--Aug. 30, 2006--CDEX Inc. (OTCBB:CEXI) announced today that it has received notification to proceed with the Missouri State Highway Patrol to conduct a Pilot Test and Field Evaluation Program. Under the program, CDEX will provide three of its Illicit Drug Detector prototypes for evaluation by the Missouri State Highway Patrol. The units will be evaluated for their effectiveness and efficacy in detecting trace amounts of methamphetamine. CDEX anticipates that the Pilot Test and Evaluation Program will be concluded by the end of 2006.
(See Story from BioSpace.com) (08/30/2006)
CDEX Inc. (CEXI.OB) Files Apparatus Patent Application For Portable, Hand-Held Methamphetamine And Illicit Drug Detector
ROCKVILLE, Md.--(BUSINESS WIRE)--July 6, 2006--CDEX, Inc. (OTCBB:CEXI - News) announced today that it has filed an apparatus patent application for its Portable, Hand-held methamphetamine and Illicit Drug Detector in preparation for its entry into the Homeland Security market. The apparatus is capable of detecting trace amounts of methamphetamine, other illicit drugs, and other chemical substances. The apparatus incorporates CDEX core technology and will provide first responders (i.e., law enforcement, fire fighters, and HAZMAT teams) with a cost effective, real time method of conducting non-contact, non-destructive, field tests of suspicious substances.
(See Story from press release) (07/06/2006)
CDEX Inc. (CEXI.OB) Second Quarter Revenue Highest In Company's History
ROCKVILLE, Md.--(BUSINESS WIRE)--June 16, 2006--CDEX, Inc. (OTCBB:CEXI.OB - News) announced today that it recorded the highest quarterly revenue in the history of the company in the fiscal second quarter, ending April 30, 2006. Revenue was $351,038 as compared to $23,860 during the second fiscal quarter of 2005. The increase of $327,177 (or 1,371%) resulted from the delivery of ValiMed (TM) medication verification systems to Baxa Corporation. Baxa represents the CDEX ValiMed product line, exclusively in the USA and Canada.
(See Story from press release) (06/16/2006) |
